Ugt2b1 Rat (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of UGT2B17 mRNA] CTD PMID:31150632 Ugt2b1 Rat (1->4)-beta-D-glucan multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of UGT2B1 mRNA CTD PMID:36331819 Ugt2b1 Rat 1,2-dichloroethane decreases expression ISO Ugt2b1 (Mus musculus) 6480464 ethylene dichloride results in decreased expression of UGT2B1 mRNA CTD PMID:28189721 and PMID:28960355 Ugt2b1 Rat 1,2-dimethylhydrazine multiple interactions EXP 6480464 [APC protein affects the susceptibility to 1 and 2-Dimethylhydrazine] which results in decreased expression of UGT2B17 mRNA CTD PMID:27840820 Ugt2b1 Rat 1-naphthaleneacetic acid increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 1-naphthaleneacetic acid CTD PMID:8302279 Ugt2b1 Rat 1-naphthol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 1-naphthol CTD PMID:8302279 Ugt2b1 Rat 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of UGT2B1 mRNA CTD PMID:30723492 Ugt2b1 Rat 17alpha-ethynylestradiol decreases activity EXP 6480464 Ethinyl Estradiol results in decreased activity of UGT2B1 protein CTD PMID:12663690 Ugt2b1 Rat 17alpha-ethynylestradiol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Ethinyl Estradiol CTD PMID:15921999 Ugt2b1 Rat 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of UGT2B1 protein CTD PMID:12663690 Ugt2b1 Rat 17alpha-ethynylestradiol multiple interactions EXP 6480464 Ursodeoxycholic Acid promotes the reaction [Ethinyl Estradiol results in decreased activity of UGT2B1 protein] and Ursodeoxycholic Acid promotes the reaction [Ethinyl Estradiol results in decreased expression of UGT2B1 protein] CTD PMID:12663690 Ugt2b1 Rat 17beta-estradiol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Estradiol CTD PMID:11836149 Ugt2b1 Rat 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of UGT2B17 mRNA and Estradiol results in increased expression of UGT2B17 protein CTD PMID:32145629 Ugt2b1 Rat 17beta-estradiol increases expression ISO UGT2B17 (Homo sapiens) 6480464 Estradiol results in increased expression of UGT2B17 mRNA CTD PMID:19619570 Ugt2b1 Rat 17beta-estradiol multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of UGT2B17 mRNA CTD PMID:19619570 Ugt2b1 Rat 17beta-hydroxy-5alpha-androstan-3-one increases metabolic processing ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased metabolism of Dihydrotestosterone CTD PMID:8798464 Ugt2b1 Rat 2,2',4,4',5,5'-hexachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:10036216 Ugt2b1 Rat 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:24878560 Ugt2b1 Rat 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:31826744 and PMID:32679240 Ugt2b1 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of UGT2B1 mRNA CTD PMID:19144771 more ... Ugt2b1 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of UGT2B4 mRNA CTD PMID:20558275 Ugt2b1 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO UGT2B17 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of UGT2B17 mRNA CTD PMID:19619570 Ugt2b1 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of UGT2B17 mRNA and [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of UGT2B17 mRNA CTD PMID:19619570 and PMID:26159488 Ugt2b1 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of UGT2B1 mRNA and Tetrachlorodibenzodioxin results in decreased expression of UGT2B17 mRNA CTD PMID:21215274 and PMID:21724226 Ugt2b1 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Ugt2b1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of UGT2B1 mRNA CTD PMID:21570461 Ugt2b1 Rat 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO Ugt2b1 (Mus musculus) 6480464 2 more ... CTD PMID:38648751 Ugt2b1 Rat 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of UGT2B1 mRNA CTD PMID:21346803 Ugt2b1 Rat 2-Ethylhexanoic acid increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 2-ethylhexanoic acid CTD PMID:8302279 Ugt2b1 Rat 2-Ethylphenol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 2-ethylphenol CTD PMID:8302279 Ugt2b1 Rat 2-naphthol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 2-naphthol CTD PMID:8302279 Ugt2b1 Rat 2-nitrofluorene increases expression EXP 6480464 2-nitrofluorene results in increased expression of UGT2B17 mRNA CTD PMID:23052194 Ugt2b1 Rat 3-Ethylphenol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 3-ethylphenol CTD PMID:8302279 Ugt2b1 Rat 3-phenylpropionic acid increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 3-phenylpropionic acid CTD PMID:8302279 Ugt2b1 Rat 3H-1,2-dithiole-3-thione increases expression EXP 6480464 1 more ... CTD PMID:19162173 and PMID:19695238 Ugt2b1 Rat 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases glucuronidation ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased glucuronidation of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone CTD PMID:31307193 Ugt2b1 Rat 4-ethylphenol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 4-ethylphenol CTD PMID:8302279 Ugt2b1 Rat 4-hydroxyphenyl retinamide increases expression ISO Ugt2b1 (Mus musculus) 6480464 Fenretinide results in increased expression of UGT2B17 mRNA CTD PMID:28973697 Ugt2b1 Rat 4-methylcyclohexan-1-ol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 4-methylcyclohexanol CTD PMID:8302279 Ugt2b1 Rat 4-methylumbelliferone increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Hymecromone CTD PMID:8302279 Ugt2b1 Rat 4-methylumbelliferone increases metabolic processing ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased metabolism of Hymecromone CTD PMID:8798464 Ugt2b1 Rat 4-methylumbelliferone multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 [UGT2B17 protein results in increased glucuronidation of Hymecromone] which results in increased chemical synthesis of 4-methylumbelliferyl glucuronide and licochalcone A inhibits the reaction [Hymecromone results in increased activity of UGT2B17 protein] CTD PMID:26875642 and PMID:33290829 Ugt2b1 Rat 4-methylumbelliferone increases activity ISO UGT2B17 (Homo sapiens) 6480464 Hymecromone results in increased activity of UGT2B17 protein CTD PMID:26875642 Ugt2b1 Rat 4-methylumbelliferone increases glucuronidation ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased glucuronidation of Hymecromone CTD PMID:33290829 Ugt2b1 Rat 4-methylumbelliferone beta-D-glucuronide multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 [UGT2B17 protein results in increased glucuronidation of Hymecromone] which results in increased chemical synthesis of 4-methylumbelliferyl glucuronide CTD PMID:33290829 Ugt2b1 Rat 4-tert-butylphenol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of butylphen CTD PMID:8302279 Ugt2b1 Rat 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole increases expression EXP 6480464 Omeprazole results in increased expression of UGT2B1 mRNA CTD PMID:25626140 Ugt2b1 Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of UGT2B1 mRNA CTD PMID:24780913 Ugt2b1 Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of UGT2B1 mRNA CTD PMID:25825206 Ugt2b1 Rat 8-Br-cAMP increases expression ISO UGT2B17 (Homo sapiens) 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of UGT2B17 mRNA CTD PMID:22079614 Ugt2b1 Rat acetamide decreases expression EXP 6480464 acetamide results in decreased expression of UGT2B1 mRNA CTD PMID:31881176 Ugt2b1 Rat aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of UGT2B17 mRNA CTD PMID:23052194 and PMID:33354967 Ugt2b1 Rat aflatoxin B1 increases expression ISO UGT2B17 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of UGT2B17 mRNA CTD PMID:21641981 Ugt2b1 Rat aflatoxin B1 decreases methylation ISO UGT2B17 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of UGT2B17 gene CTD PMID:27153756 Ugt2b1 Rat aldrin increases expression ISO Ugt2b1 (Mus musculus) 6480464 Aldrin results in increased expression of UGT2B1 mRNA CTD PMID:18579281 Ugt2b1 Rat all-trans-retinoic acid decreases expression ISO UGT2B17 (Homo sapiens) 6480464 Tretinoin results in decreased expression of UGT2B17 mRNA CTD PMID:23724009 Ugt2b1 Rat alpha-hexachlorocyclohexane increases expression EXP 6480464 alpha-hexachlorocyclohexane results in increased expression of UGT2B1 mRNA CTD PMID:16940010 and PMID:17785943 Ugt2b1 Rat amentoflavone decreases activity ISO UGT2B17 (Homo sapiens) 6480464 amentoflavone results in decreased activity of UGT2B17 protein CTD PMID:29470958 Ugt2b1 Rat amiodarone affects expression EXP 6480464 Amiodarone affects the expression of UGT2B1 mRNA CTD PMID:18355885 Ugt2b1 Rat amitriptyline affects expression EXP 6480464 Amitriptyline affects the expression of UGT2B1 mRNA CTD PMID:18355885 Ugt2b1 Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of UGT2B1 mRNA CTD PMID:16483693 Ugt2b1 Rat androstane-3,17-diol increases metabolic processing ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased metabolism of Androstane-3 and 17-diol CTD PMID:8798464 Ugt2b1 Rat androsterone increases metabolic processing ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased metabolism of Androsterone CTD PMID:8798464 Ugt2b1 Rat aristolochic acid A multiple interactions EXP 6480464 [aristolochic acid I co-treated with aristolochic acid II] results in increased expression of UGT2B17 mRNA CTD PMID:23912714 Ugt2b1 Rat Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of UGT2B1 mRNA CTD PMID:18178546 Ugt2b1 Rat Aroclor 1254 affects expression ISO UGT2B17 (Homo sapiens) 6480464 Chlorodiphenyl (54% Chlorine) affects the expression of UGT2B17 mRNA CTD PMID:17851650 Ugt2b1 Rat atrazine affects expression EXP 6480464 Atrazine affects the expression of UGT2B17 mRNA CTD PMID:22285353 Ugt2b1 Rat benzene affects expression EXP 6480464 Benzene affects the expression of UGT2B1 mRNA CTD PMID:15878777 Ugt2b1 Rat benzo[a]pyrene increases expression ISO Ugt2b1 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of UGT2B1 mRNA CTD PMID:19770486 Ugt2b1 Rat benzo[a]pyrene decreases expression ISO UGT2B17 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of UGT2B17 mRNA CTD PMID:32234424 Ugt2b1 Rat benzyl alcohol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Benzyl Alcohol CTD PMID:8302279 Ugt2b1 Rat bezafibrate increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Bezafibrate CTD PMID:8302279 Ugt2b1 Rat bicalutamide decreases expression ISO UGT2B17 (Homo sapiens) 6480464 bicalutamide results in decreased expression of UGT2B17 mRNA CTD PMID:15638997 Ugt2b1 Rat biphenyl-4-ol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 4-phenylphenol CTD PMID:11836149 more ... Ugt2b1 Rat bis(2-ethylhexyl) phthalate decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of UGT2B1 mRNA CTD PMID:19850644 Ugt2b1 Rat bis(2-ethylhexyl) phthalate multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of UGT2B1 mRNA] CTD PMID:19850644 Ugt2b1 Rat bisphenol A increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of bisphenol A CTD PMID:10333482 more ... Ugt2b1 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of UGT2B1 mRNA and bisphenol A results in increased expression of UGT2B17 protein CTD PMID:29960846 and PMID:32145629 Ugt2b1 Rat bisphenol A increases expression ISO Ugt2b1 (Mus musculus) 6480464 bisphenol A results in increased expression of UGT2B1 mRNA CTD PMID:30245210 Ugt2b1 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of UGT2B1 mRNA CTD PMID:30903817 Ugt2b1 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of UGT2B1 mRNA more ... CTD PMID:12230427 and PMID:25181051 Ugt2b1 Rat bisphenol F increases expression ISO Ugt2b1 (Mus musculus) 6480464 bisphenol F results in increased expression of UGT2B1 mRNA CTD PMID:38685157 Ugt2b1 Rat bromuconazole increases expression EXP 6480464 bromuconazole results in increased expression of UGT2B1 mRNA CTD PMID:33789219 Ugt2b1 Rat buta-1,3-diene decreases expression ISO Ugt2b1 (Mus musculus) 6480464 1 and 3-butadiene results in decreased expression of UGT2B1 mRNA CTD PMID:29038090 Ugt2b1 Rat butylated hydroxyanisole decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Butylated Hydroxyanisole results in decreased expression of UGT2B1 mRNA CTD PMID:19144771 Ugt2b1 Rat cadmium acetate affects expression EXP 6480464 cadmium acetate affects the expression of UGT2B17 mRNA CTD PMID:16249259 Ugt2b1 Rat calcitriol decreases expression ISO UGT2B17 (Homo sapiens) 6480464 Calcitriol results in decreased expression of UGT2B17 mRNA CTD PMID:21592394 Ugt2b1 Rat calcitriol multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of UGT2B17 mRNA CTD PMID:21592394 Ugt2b1 Rat carbamazepine increases expression EXP 6480464 Carbamazepine results in increased expression of UGT2B1 mRNA CTD PMID:17381134 Ugt2b1 Rat carbon nanotube decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25620056 Ugt2b1 Rat chloramphenicol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Chloramphenicol CTD PMID:8302279 Ugt2b1 Rat chlorogenic acid decreases activity ISO UGT2B17 (Homo sapiens) 6480464 Chlorogenic Acid results in decreased activity of UGT2B17 protein CTD PMID:35868516 Ugt2b1 Rat chlorohydrocarbon multiple interactions EXP 6480464 [Hydrocarbons and Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of UGT2B1 mRNA CTD PMID:30744511 Ugt2b1 Rat ciprofibrate increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of ciprofibrate CTD PMID:8302279 Ugt2b1 Rat cis-caffeic acid decreases activity ISO UGT2B17 (Homo sapiens) 6480464 caffeic acid results in decreased activity of UGT2B17 protein CTD PMID:35868516 Ugt2b1 Rat cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of UGT2B17 protein CTD PMID:22023808 Ugt2b1 Rat clofibrate increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Clofibrate CTD PMID:8302279 Ugt2b1 Rat clofibrate decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Clofibrate results in decreased expression of UGT2B1 mRNA CTD PMID:22496397 Ugt2b1 Rat clofibrate multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 [Clofibrate co-treated with PPARA protein mutant form] results in increased expression of UGT2B1 mRNA CTD PMID:22496397 Ugt2b1 Rat clofibric acid increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Clofibric Acid CTD PMID:8302279 Ugt2b1 Rat clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of UGT2B1 mRNA CTD PMID:17602206 Ugt2b1 Rat clomipramine affects expression EXP 6480464 Clomipramine affects the expression of UGT2B1 mRNA CTD PMID:18355885 Ugt2b1 Rat cortisol increases expression EXP 6480464 Hydrocortisone results in increased expression of UGT2B1 mRNA CTD PMID:10476907 Ugt2b1 Rat cyclosporin A decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Cyclosporine results in decreased expression of UGT2B1 mRNA CTD PMID:19770486 Ugt2b1 Rat cyclosporin A decreases expression ISO UGT2B17 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of UGT2B17 mRNA CTD PMID:27989131 Ugt2b1 Rat cylindrospermopsin decreases expression ISO UGT2B17 (Homo sapiens) 6480464 cylindrospermopsin results in decreased expression of UGT2B17 mRNA CTD PMID:30905859 Ugt2b1 Rat cylindrospermopsin decreases expression ISO Ugt2b1 (Mus musculus) 6480464 cylindrospermopsin results in decreased expression of UGT2B1 mRNA CTD PMID:20936652 Ugt2b1 Rat cyproconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole] results in increased expression of UGT2B1 mRNA CTD PMID:29038839 Ugt2b1 Rat cyproconazole increases expression EXP 6480464 cyproconazole results in increased expression of UGT2B1 mRNA CTD PMID:29038839 Ugt2b1 Rat daidzein increases expression ISO UGT2B17 (Homo sapiens) 6480464 daidzein results in increased expression of UGT2B17 mRNA CTD PMID:16865672 Ugt2b1 Rat DDE multiple interactions EXP 6480464 [2 more ... CTD PMID:24878560 Ugt2b1 Rat decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of UGT2B1 mRNA CTD PMID:32679240 Ugt2b1 Rat dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of UGT2B1 mRNA and Dexamethasone results in increased expression of UGT2B17 mRNA CTD PMID:11328961 more ... Ugt2b1 Rat dexamethasone affects expression EXP 6480464 Dexamethasone affects the expression of UGT2B1 mRNA CTD PMID:15102944 Ugt2b1 Rat Diallyl sulfide increases expression EXP 6480464 allyl sulfide results in increased expression of UGT2B4 mRNA CTD PMID:19695238 Ugt2b1 Rat dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of UGT2B1 mRNA CTD PMID:15901914 Ugt2b1 Rat dichloroacetic acid decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Dichloroacetic Acid results in decreased expression of UGT2B1 mRNA CTD PMID:28962523 Ugt2b1 Rat diclofenac increases glucuronidation ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased glucuronidation of Diclofenac CTD PMID:15843492 and PMID:22265884 Ugt2b1 Rat diethylstilbestrol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Diethylstilbestrol CTD PMID:11836149 Ugt2b1 Rat diethylstilbestrol increases expression ISO Ugt2b1 (Mus musculus) 6480464 Diethylstilbestrol results in increased expression of UGT2B1 mRNA CTD PMID:20163289 Ugt2b1 Rat Diosbulbin B decreases expression ISO Ugt2b1 (Mus musculus) 6480464 diosbulbin B results in decreased expression of UGT2B1 mRNA CTD PMID:39368342 Ugt2b1 Rat diquat decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Diquat results in decreased expression of UGT2B17 protein CTD PMID:36851058 Ugt2b1 Rat doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of UGT2B1 mRNA CTD PMID:26335259 Ugt2b1 Rat doxorubicin multiple interactions EXP 6480464 [Taurine binds to Zinc] inhibits the reaction [Doxorubicin results in decreased expression of UGT2B1 mRNA] CTD PMID:26335259 Ugt2b1 Rat elemental selenium increases expression EXP 6480464 Selenium deficiency results in increased expression of UGT2B1 mRNA CTD PMID:11444866 Ugt2b1 Rat endosulfan multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of UGT2B17 mRNA CTD PMID:26159488 Ugt2b1 Rat endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of UGT2B1 mRNA CTD PMID:29391264 Ugt2b1 Rat endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of UGT2B17 mRNA CTD PMID:29391264 Ugt2b1 Rat epoxiconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole] results in increased expression of UGT2B1 mRNA CTD PMID:29038839 Ugt2b1 Rat epoxiconazole increases expression EXP 6480464 epoxiconazole results in increased expression of UGT2B1 mRNA CTD PMID:29038839 Ugt2b1 Rat equol increases expression ISO UGT2B17 (Homo sapiens) 6480464 Equol results in increased expression of UGT2B17 mRNA CTD PMID:16865672 Ugt2b1 Rat ethyl methanesulfonate increases expression ISO UGT2B17 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of UGT2B17 mRNA CTD PMID:23649840 Ugt2b1 Rat eugenol increases metabolic processing ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased metabolism of Eugenol CTD PMID:8798464 Ugt2b1 Rat felbamate increases expression EXP 6480464 felbamate results in increased expression of UGT2B1 mRNA CTD PMID:17381134 Ugt2b1 Rat fipronil increases expression ISO Ugt2b1 (Mus musculus) 6480464 fipronil results in increased expression of UGT2B1 mRNA CTD PMID:23962444 Ugt2b1 Rat fipronil increases expression EXP 6480464 fipronil results in increased expression of UGT2B1 mRNA CTD PMID:23962444 Ugt2b1 Rat fluconazole increases expression EXP 6480464 Fluconazole results in increased expression of UGT2B1 mRNA CTD PMID:16643972 Ugt2b1 Rat flumequine decreases expression ISO Ugt2b1 (Mus musculus) 6480464 flumequine results in decreased expression of UGT2B1 mRNA CTD PMID:23681119 Ugt2b1 Rat flumequine multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 [flumequine co-treated with 2-amino-3 more ... CTD PMID:23681119 Ugt2b1 Rat flurbiprofen increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Flurbiprofen CTD PMID:8302279 Ugt2b1 Rat flutamide increases expression EXP 6480464 Flutamide results in increased expression of UGT2B17 mRNA CTD PMID:24136188 Ugt2b1 Rat formaldehyde increases expression ISO UGT2B17 (Homo sapiens) 6480464 Formaldehyde results in increased expression of UGT2B17 mRNA CTD PMID:23649840 Ugt2b1 Rat fumonisin B1 multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 [NR1H2 protein affects the susceptibility to fumonisin B1] which affects the expression of UGT2B1 mRNA and [NR1H3 protein affects the susceptibility to fumonisin B1] which affects the expression of UGT2B1 mRNA CTD PMID:30448865 Ugt2b1 Rat gabapentin increases expression EXP 6480464 gabapentin results in increased expression of UGT2B1 mRNA CTD PMID:17381134 Ugt2b1 Rat genistein multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 Genistein inhibits the reaction [Acetaminophen results in decreased expression of UGT2B1 mRNA] CTD PMID:23333575 Ugt2b1 Rat genistein increases expression ISO UGT2B17 (Homo sapiens) 6480464 Genistein results in increased expression of UGT2B17 mRNA CTD PMID:16865672 Ugt2b1 Rat glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of UGT2B17 mRNA CTD PMID:24136188 Ugt2b1 Rat glutathione increases expression EXP 6480464 Glutathione deficiency results in increased expression of UGT2B1 mRNA and Glutathione deficiency results in increased expression of UGT2B4 mRNA CTD PMID:15345336 Ugt2b1 Rat hexachlorobenzene increases expression EXP 6480464 Hexachlorobenzene results in increased expression of UGT2B1 mRNA CTD PMID:15159207 Ugt2b1 Rat hydratropic acid increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of hydratropic acid CTD PMID:8302279 Ugt2b1 Rat ibuprofen increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Ibuprofen CTD PMID:8302279 Ugt2b1 Rat imipramine affects expression EXP 6480464 Imipramine affects the expression of UGT2B1 mRNA CTD PMID:18355885 Ugt2b1 Rat indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of UGT2B1 mRNA CTD PMID:21396975 Ugt2b1 Rat indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of UGT2B17 mRNA CTD PMID:22129741 Ugt2b1 Rat iron atom decreases expression EXP 6480464 Iron deficiency results in decreased expression of UGT2B17 mRNA CTD PMID:16629162 Ugt2b1 Rat iron(0) decreases expression EXP 6480464 Iron deficiency results in decreased expression of UGT2B17 mRNA CTD PMID:16629162 Ugt2b1 Rat ketoconazole affects expression EXP 6480464 Ketoconazole affects the expression of UGT2B1 mRNA CTD PMID:18355885 Ugt2b1 Rat ketoprofen increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Ketoprofen CTD PMID:8302279 Ugt2b1 Rat L-ascorbic acid multiple interactions EXP 6480464 UGT2B17 protein affects the reaction [Phenobarbital results in increased abundance of Ascorbic Acid] CTD PMID:8263600 Ugt2b1 Rat lansoprazole increases expression EXP 6480464 Lansoprazole results in increased expression of UGT2B1 mRNA CTD PMID:25626140 Ugt2b1 Rat Lasiocarpine increases expression EXP 6480464 lasiocarpine results in increased expression of UGT2B17 mRNA CTD PMID:32419051 Ugt2b1 Rat Licochalcone A multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 licochalcone A inhibits the reaction [Hymecromone results in increased activity of UGT2B17 protein] CTD PMID:26875642 Ugt2b1 Rat lipopolysaccharide decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Lipopolysaccharides results in decreased expression of UGT2B1 mRNA CTD PMID:27339419 Ugt2b1 Rat lithocholic acid increases expression EXP 6480464 Lithocholic Acid results in increased expression of UGT2B17 mRNA CTD PMID:21311750 Ugt2b1 Rat lorcaserin multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased carbamoylation of and results in increased glucuronidation of lorcaserin CTD PMID:22259019 Ugt2b1 Rat MeIQx multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 [flumequine co-treated with 2-amino-3 more ... CTD PMID:23681119 Ugt2b1 Rat methyl methanesulfonate increases expression ISO UGT2B17 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of UGT2B17 mRNA CTD PMID:23649840 Ugt2b1 Rat methylmercury chloride multiple interactions EXP 6480464 [Hydrocarbons and Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of UGT2B1 mRNA CTD PMID:30744511 Ugt2b1 Rat Mitotane increases expression EXP 6480464 Mitotane results in increased expression of UGT2B1 mRNA CTD PMID:10036216 Ugt2b1 Rat Muraglitazar decreases expression EXP 6480464 muraglitazar results in decreased expression of UGT2B1 mRNA CTD PMID:21515302 Ugt2b1 Rat N-nitrosodiethylamine decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Diethylnitrosamine results in decreased expression of UGT2B1 mRNA CTD PMID:24535843 Ugt2b1 Rat N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of UGT2B1 mRNA more ... CTD PMID:17602206 more ... Ugt2b1 Rat N-nitrosodiethylamine multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of UGT2B1 mRNA] CTD PMID:17942915 Ugt2b1 Rat N-nitrosodiethylamine increases expression ISO Ugt2b1 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of UGT2B1 mRNA CTD PMID:17942915 Ugt2b1 Rat N-Vinyl-2-pyrrolidone multiple interactions EXP 6480464 [N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of UGT2B1 mRNA CTD PMID:22037397 Ugt2b1 Rat naproxen increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Naproxen CTD PMID:8302279 Ugt2b1 Rat nefazodone increases expression EXP 6480464 nefazodone results in increased expression of UGT2B17 mRNA CTD PMID:24136188 Ugt2b1 Rat nelfinavir increases expression EXP 6480464 Nelfinavir results in increased expression of UGT2B1 mRNA CTD PMID:16408618 Ugt2b1 Rat nimesulide increases expression EXP 6480464 nimesulide results in increased expression of UGT2B17 mRNA CTD PMID:24136188 Ugt2b1 Rat Nonylphenol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of nonylphenol CTD PMID:11836149 Ugt2b1 Rat O-methyleugenol decreases expression ISO UGT2B17 (Homo sapiens) 6480464 methyleugenol results in decreased expression of UGT2B17 mRNA CTD PMID:32234424 Ugt2b1 Rat oltipraz decreases expression ISO Ugt2b1 (Mus musculus) 6480464 oltipraz results in decreased expression of UGT2B1 mRNA CTD PMID:19144771 Ugt2b1 Rat oltipraz increases expression EXP 6480464 oltipraz results in increased expression of UGT2B1 mRNA CTD PMID:18418891 Ugt2b1 Rat oltipraz multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 [oltipraz co-treated with NFE2L2 protein mutant form] results in decreased expression of UGT2B1 mRNA CTD PMID:22496397 Ugt2b1 Rat omeprazole increases expression EXP 6480464 Omeprazole results in increased expression of UGT2B1 mRNA CTD PMID:25626140 Ugt2b1 Rat orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of UGT2B1 mRNA CTD PMID:23665939 Ugt2b1 Rat p-cresol increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of 4-cresol CTD PMID:8302279 Ugt2b1 Rat p-toluidine increases expression EXP 6480464 4-toluidine results in increased expression of UGT2B1 mRNA CTD PMID:27638505 Ugt2b1 Rat pantoprazole increases expression EXP 6480464 pantoprazole results in increased expression of UGT2B1 mRNA CTD PMID:25626140 Ugt2b1 Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of UGT2B1 mRNA CTD PMID:17126469 more ... Ugt2b1 Rat paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of UGT2B1 mRNA CTD PMID:30723492 Ugt2b1 Rat paracetamol multiple interactions EXP 6480464 [Acetaminophen co-treated with Uranium analog] results in decreased expression of UGT2B1 mRNA CTD PMID:17126469 Ugt2b1 Rat paracetamol multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 Genistein inhibits the reaction [Acetaminophen results in decreased expression of UGT2B1 mRNA] more ... CTD PMID:23333575 more ... Ugt2b1 Rat paracetamol decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Acetaminophen results in decreased expression of UGT2B1 mRNA CTD PMID:23333575 more ... Ugt2b1 Rat paracetamol affects expression ISO Ugt2b1 (Mus musculus) 6480464 Acetaminophen affects the expression of UGT2B1 mRNA CTD PMID:17562736 Ugt2b1 Rat pectolinarigenin increases glucuronidation ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased glucuronidation of pectolinarigenin CTD PMID:37797876 Ugt2b1 Rat perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of UGT2B1 mRNA CTD PMID:19162173 Ugt2b1 Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of UGT2B1 mRNA CTD PMID:36331819 Ugt2b1 Rat perfluorooctane-1-sulfonic acid affects expression ISO Ugt2b1 (Mus musculus) 6480464 perfluorooctane sulfonic acid affects the expression of UGT2B1 mRNA CTD PMID:19429403 Ugt2b1 Rat perfluorooctanoic acid decreases expression ISO Ugt2b1 (Mus musculus) 6480464 perfluorooctanoic acid results in decreased expression of UGT2B1 mRNA and perfluorooctanoic acid results in decreased expression of UGT2B17 mRNA CTD PMID:17681415 and PMID:18467677 Ugt2b1 Rat perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of UGT2B17 mRNA CTD PMID:28511854 Ugt2b1 Rat perfluorooctanoic acid affects expression ISO Ugt2b1 (Mus musculus) 6480464 perfluorooctanoic acid affects the expression of UGT2B1 mRNA CTD PMID:19429403 Ugt2b1 Rat perfluorooctanoic acid multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 PPARA protein promotes the reaction [perfluorooctanoic acid results in decreased expression of UGT2B17 mRNA] CTD PMID:18467677 Ugt2b1 Rat phenformin increases expression EXP 6480464 Phenformin results in increased expression of UGT2B1 mRNA CTD PMID:31324951 Ugt2b1 Rat phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of UGT2B1 mRNA more ... CTD PMID:10036216 more ... Ugt2b1 Rat phenobarbital increases expression ISO Ugt2b1 (Mus musculus) 6480464 Phenobarbital results in increased expression of UGT2B1 mRNA CTD PMID:19760798 Ugt2b1 Rat phenobarbital decreases expression ISO UGT2B17 (Homo sapiens) 6480464 Phenobarbital results in decreased expression of UGT2B17 mRNA CTD PMID:19084549 Ugt2b1 Rat phenobarbital multiple interactions EXP 6480464 UGT2B17 protein affects the reaction [Phenobarbital results in increased abundance of Ascorbic Acid] CTD PMID:8263600 Ugt2b1 Rat phenobarbital increases activity EXP 6480464 Phenobarbital results in increased activity of UGT2B17 protein CTD PMID:8263600 Ugt2b1 Rat phenytoin increases expression EXP 6480464 Phenytoin results in increased expression of UGT2B1 mRNA CTD PMID:17381134 Ugt2b1 Rat phloretin decreases activity ISO UGT2B17 (Homo sapiens) 6480464 Phloretin results in decreased activity of UGT2B17 protein CTD PMID:35868516 Ugt2b1 Rat phlorizin decreases activity ISO UGT2B17 (Homo sapiens) 6480464 Phlorhizin results in decreased activity of UGT2B17 protein CTD PMID:35868516 Ugt2b1 Rat piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of UGT2B1 mRNA and Piperonyl Butoxide results in increased expression of UGT2B17 mRNA CTD PMID:17498859 more ... Ugt2b1 Rat piperonyl butoxide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of UGT2B17 mRNA and Triterpenes promotes the reaction [Piperonyl Butoxide results in increased expression of UGT2B17 mRNA] CTD PMID:18544911 and PMID:18648771 Ugt2b1 Rat pirinixic acid multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 PPARA protein promotes the reaction [pirinixic acid results in decreased expression of UGT2B17 mRNA] CTD PMID:18467677 Ugt2b1 Rat pirinixic acid decreases expression ISO Ugt2b1 (Mus musculus) 6480464 pirinixic acid results in decreased expression of UGT2B1 mRNA and pirinixic acid results in decreased expression of UGT2B17 mRNA CTD PMID:18467677 more ... Ugt2b1 Rat pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of UGT2B1 mRNA and pirinixic acid results in decreased expression of UGT2B17 mRNA CTD PMID:19162173 and PMID:22484513 Ugt2b1 Rat pirprofen increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of pirprofen CTD PMID:8302279 Ugt2b1 Rat poly(I:C) decreases expression EXP 6480464 Poly I-C results in decreased expression of UGT2B1 mRNA CTD PMID:23939143 Ugt2b1 Rat pravastatin decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Pravastatin results in decreased expression of UGT2B1 mRNA CTD PMID:27225895 Ugt2b1 Rat pravastatin decreases expression EXP 6480464 Pravastatin results in decreased expression of UGT2B1 mRNA CTD PMID:27225895 Ugt2b1 Rat pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of UGT2B1 mRNA CTD PMID:19162173 and PMID:22037397 Ugt2b1 Rat prochloraz increases expression EXP 6480464 prochloraz results in increased expression of UGT2B1 mRNA CTD PMID:29038839 Ugt2b1 Rat propiconazole increases expression ISO Ugt2b1 (Mus musculus) 6480464 propiconazole results in increased expression of UGT2B1 mRNA CTD PMID:21278054 Ugt2b1 Rat propiconazole increases expression EXP 6480464 propiconazole results in increased expression of UGT2B1 mRNA and propiconazole results in increased expression of UGT2B17 mRNA CTD PMID:16643972 more ... Ugt2b1 Rat quercetin 3-O-beta-D-galactopyranoside multiple interactions ISO Ugt2b1 (Mus musculus) 6480464 hyperoside inhibits the reaction [Acetaminophen results in decreased expression of UGT2B1 mRNA] CTD PMID:26772156 Ugt2b1 Rat quercetin 3-O-beta-D-galactopyranoside increases expression ISO Ugt2b1 (Mus musculus) 6480464 hyperoside results in increased expression of UGT2B1 mRNA CTD PMID:26772156 Ugt2b1 Rat quinolines increases expression EXP 6480464 Quinolines results in increased expression of UGT2B1 mRNA CTD PMID:9176741 Ugt2b1 Rat rabeprazole increases expression EXP 6480464 Rabeprazole results in increased expression of UGT2B1 mRNA CTD PMID:25626140 Ugt2b1 Rat rotenone increases expression EXP 6480464 Rotenone results in increased expression of UGT2B1 mRNA CTD PMID:28374803 Ugt2b1 Rat selenium atom increases expression EXP 6480464 Selenium deficiency results in increased expression of UGT2B1 mRNA CTD PMID:11444866 Ugt2b1 Rat senecionine decreases expression ISO Ugt2b1 (Mus musculus) 6480464 senecionine results in decreased expression of UGT2B1 mRNA CTD PMID:31606820 Ugt2b1 Rat sodium arsenite increases expression ISO UGT2B17 (Homo sapiens) 6480464 sodium arsenite results in increased expression of UGT2B17 mRNA CTD PMID:38568856 Ugt2b1 Rat tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of UGT2B1 mRNA CTD PMID:8706011 Ugt2b1 Rat taurine multiple interactions EXP 6480464 [Taurine binds to Zinc] inhibits the reaction [Doxorubicin results in decreased expression of UGT2B1 mRNA] more ... CTD PMID:26335259 Ugt2b1 Rat tert-butyl ethyl ether increases expression EXP 6480464 ethyl tert-butyl ether results in increased expression of UGT2B1 protein CTD PMID:24090815 Ugt2b1 Rat Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of UGT2B1 mRNA CTD PMID:21515302 Ugt2b1 Rat testosterone increases expression ISO Ugt2b1 (Mus musculus) 6480464 Testosterone results in increased expression of UGT2B1 mRNA CTD PMID:20844152 Ugt2b1 Rat testosterone multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of UGT2B17 mRNA CTD PMID:21592394 Ugt2b1 Rat testosterone decreases expression ISO UGT2B17 (Homo sapiens) 6480464 Testosterone results in decreased expression of UGT2B17 mRNA CTD PMID:21592394 Ugt2b1 Rat testosterone increases expression ISO UGT2B17 (Homo sapiens) 6480464 Testosterone results in increased expression of UGT2B17 mRNA CTD PMID:21880219 Ugt2b1 Rat testosterone increases metabolic processing ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased metabolism of Testosterone CTD PMID:8798464 Ugt2b1 Rat testosterone increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Testosterone CTD PMID:11836149 and PMID:8302279 Ugt2b1 Rat Testosterone propionate decreases expression EXP 6480464 Testosterone Propionate results in decreased expression of UGT2B1 mRNA CTD PMID:16829708 Ugt2b1 Rat tetrachloromethane decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of UGT2B1 mRNA CTD PMID:27339419 more ... Ugt2b1 Rat tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of UGT2B1 mRNA CTD PMID:32380060 Ugt2b1 Rat tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of UGT2B17 mRNA] CTD PMID:31150632 Ugt2b1 Rat tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of UGT2B1 mRNA and Carbon Tetrachloride results in decreased expression of UGT2B17 mRNA CTD PMID:31150632 Ugt2b1 Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of UGT2B17 mRNA and Thioacetamide results in increased expression of UGT2B4 mRNA CTD PMID:37008694 Ugt2b1 Rat thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of UGT2B17 mRNA CTD PMID:34492290 Ugt2b1 Rat trans-caffeic acid decreases activity ISO UGT2B17 (Homo sapiens) 6480464 caffeic acid results in decreased activity of UGT2B17 protein CTD PMID:35868516 Ugt2b1 Rat triadimefon increases expression EXP 6480464 triadimefon results in increased expression of UGT2B1 mRNA and triadimefon results in increased expression of UGT2B17 mRNA CTD PMID:16643972 more ... Ugt2b1 Rat trichloroethene decreases expression ISO Ugt2b1 (Mus musculus) 6480464 Trichloroethylene results in decreased expression of UGT2B1 mRNA CTD PMID:25549359 Ugt2b1 Rat trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of UGT2B17 mRNA CTD PMID:33387578 Ugt2b1 Rat trifluralin increases expression EXP 6480464 Trifluralin results in increased expression of UGT2B1 mRNA CTD PMID:18582544 Ugt2b1 Rat triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of UGT2B1 mRNA CTD PMID:30589522 Ugt2b1 Rat trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of UGT2B17 mRNA CTD PMID:24136188 Ugt2b1 Rat uranium atom multiple interactions EXP 6480464 [Acetaminophen co-treated with Uranium analog] results in decreased expression of UGT2B1 mRNA CTD PMID:17126469 Ugt2b1 Rat ursodeoxycholic acid multiple interactions EXP 6480464 Ursodeoxycholic Acid promotes the reaction [Ethinyl Estradiol results in decreased activity of UGT2B1 protein] and Ursodeoxycholic Acid promotes the reaction [Ethinyl Estradiol results in decreased expression of UGT2B1 protein] CTD PMID:12663690 Ugt2b1 Rat ursodeoxycholic acid increases glucuronidation ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased glucuronidation of Ursodeoxycholic Acid CTD PMID:31299240 Ugt2b1 Rat valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of UGT2B17 mRNA CTD PMID:24136188 Ugt2b1 Rat valproic acid decreases expression ISO UGT2B17 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of UGT2B17 mRNA CTD PMID:29154799 Ugt2b1 Rat valproic acid decreases methylation ISO UGT2B17 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of UGT2B17 gene CTD PMID:29154799 Ugt2b1 Rat valproic acid increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Valproic Acid CTD PMID:8302279 Ugt2b1 Rat valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of UGT2B1 mRNA CTD PMID:17381134 Ugt2b1 Rat vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of UGT2B17 mRNA CTD PMID:22285353 Ugt2b1 Rat vitamin E decreases expression EXP 6480464 Vitamin E results in decreased expression of UGT2B4 mRNA CTD PMID:28923436 Ugt2b1 Rat vorinostat increases glucuronidation ISO UGT2B17 (Homo sapiens) 6480464 UGT2B17 protein results in increased glucuronidation of vorinostat CTD PMID:25393417 Ugt2b1 Rat vorinostat multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 [Warfarin binds to and results in decreased activity of UGT2B17 protein] which results in decreased glucuronidation of vorinostat and Warfarin inhibits the reaction [UGT2B17 protein results in increased glucuronidation of vorinostat] CTD PMID:25393417 Ugt2b1 Rat warfarin multiple interactions ISO UGT2B17 (Homo sapiens) 6480464 [Warfarin binds to and results in decreased activity of UGT2B17 protein] which results in decreased glucuronidation of vorinostat more ... CTD PMID:25393417 Ugt2b1 Rat zaragozic acid A decreases expression ISO Ugt2b1 (Mus musculus) 6480464 squalestatin 1 results in decreased expression of UGT2B1 mRNA CTD PMID:27225895 Ugt2b1 Rat zaragozic acid A increases expression EXP 6480464 squalestatin 1 results in increased expression of UGT2B1 mRNA CTD PMID:27225895 Ugt2b1 Rat zidovudine increases glucuronidation EXP 6480464 UGT2B1 protein results in increased glucuronidation of Zidovudine CTD PMID:8302279 Ugt2b1 Rat zinc acetate multiple interactions EXP 6480464 [Taurine co-treated with Zinc Acetate] results in increased expression of UGT2B1 mRNA CTD PMID:26335259 Ugt2b1 Rat zinc atom multiple interactions EXP 6480464 [Taurine binds to Zinc] inhibits the reaction [Doxorubicin results in decreased expression of UGT2B1 mRNA] and [Taurine binds to Zinc] which results in increased expression of UGT2B1 mRNA CTD PMID:26335259 Ugt2b1 Rat zinc(0) multiple interactions EXP 6480464 [Taurine binds to Zinc] inhibits the reaction [Doxorubicin results in decreased expression of UGT2B1 mRNA] and [Taurine binds to Zinc] which results in increased expression of UGT2B1 mRNA CTD PMID:26335259